K107181PAnti-MYOZ2 Polyclonal Antibody
Anti-MYOZ2 Polyclonal Antibody 應(yīng)用WB 稀釋比例WB 1:5000-8000. 交叉反應(yīng)Human
訪問(wèn)次數(shù):717 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107180PAnti-PTPN7 Polyclonal Antibody
Anti-PTPN7 Polyclonal Antibody 應(yīng)用WB 稀釋比例WB 1:5000-8000. 交叉反應(yīng)Human
訪問(wèn)次數(shù):763 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107179PAnti-ECP Polyclonal Antibody
Anti-ECP Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human Mouse Rat
訪問(wèn)次數(shù):785 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107178PAnti-NCBP2 Polyclonal Antibody
Anti-NCBP2 Polyclonal Antibody 應(yīng) 用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human Mouse
訪問(wèn)次數(shù):755 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107177PAnti-SKP1 Polyclonal Antibody
Anti-SKP1 Polyclonal Antibody 應(yīng) 用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human Rat
訪問(wèn)次數(shù):743 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107176PAnti-CDKN2C Polyclonal Antibody
Anti-CDKN2C Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human Mouse
訪問(wèn)次數(shù):666 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107175PAnti-CDKN2A Polyclonal Antibody
Anti-CDKN2A Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human
訪問(wèn)次數(shù):756 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107174PAnti-JDP2 Polyclonal Antibody
Anti-JDP2 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:10000-15000. IHC 1:50-200. 交叉反應(yīng)Human Mouse Rat
訪問(wèn)次數(shù):796 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107173PAnti-Pin1 Polyclonal Antibody
Anti-Pin1 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human Mouse Rat
訪問(wèn)次數(shù):736 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14
K107172PAnti-TEBP Polyclonal Antibody
Anti-TEBP Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:2000-5000. IHC 1:50-200. 交叉反應(yīng)Human Mouse Rat
訪問(wèn)次數(shù):625 產(chǎn)品價(jià)格:面議 廠商性質(zhì):生產(chǎn)廠家 更新日期:2022-08-14